EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $965,617 | -92.7% | 48,305 | -79.9% | 0.00% | -100.0% |
| Q3 2021 | $13,242,000 | +106.4% | 239,933 | +65.3% | 0.01% | +100.0% |
| Q2 2021 | $6,417,000 | +5033.6% | 145,184 | +4652.3% | 0.00% | – |
| Q1 2021 | $125,000 | -6.7% | 3,055 | +13.7% | 0.00% | – |
| Q4 2020 | $134,000 | +235.0% | 2,686 | +196.5% | 0.00% | – |
| Q3 2020 | $40,000 | -31.0% | 906 | -26.8% | 0.00% | – |
| Q2 2020 | $58,000 | +2800.0% | 1,238 | +2426.5% | 0.00% | – |
| Q1 2020 | $2,000 | -97.2% | 49 | -95.9% | 0.00% | – |
| Q4 2019 | $71,000 | -2.7% | 1,186 | -8.7% | 0.00% | – |
| Q3 2019 | $73,000 | +2.8% | 1,299 | +1.7% | 0.00% | – |
| Q2 2019 | $71,000 | +446.2% | 1,277 | +395.0% | 0.00% | – |
| Q1 2019 | $13,000 | +30.0% | 258 | +7.9% | 0.00% | – |
| Q4 2018 | $10,000 | -61.5% | 239 | -37.1% | 0.00% | – |
| Q3 2018 | $26,000 | -10.3% | 380 | -0.3% | 0.00% | – |
| Q2 2018 | $29,000 | +81.2% | 381 | +24.1% | 0.00% | – |
| Q1 2018 | $16,000 | 0.0% | 307 | 0.0% | 0.00% | – |
| Q4 2017 | $16,000 | -96.7% | 307 | -96.3% | 0.00% | – |
| Q3 2017 | $491,000 | +149.2% | 8,238 | +229.9% | 0.00% | – |
| Q2 2017 | $197,000 | +302.0% | 2,497 | +323.9% | 0.00% | – |
| Q1 2017 | $49,000 | -97.7% | 589 | -97.8% | 0.00% | -100.0% |
| Q4 2016 | $2,145,000 | -74.7% | 27,170 | -77.6% | 0.00% | -77.8% |
| Q3 2016 | $8,479,000 | +58.3% | 121,130 | -12.3% | 0.01% | +50.0% |
| Q2 2016 | $5,356,000 | +0.7% | 138,096 | +5.2% | 0.01% | 0.0% |
| Q1 2016 | $5,317,000 | -50.0% | 131,268 | +9.5% | 0.01% | -53.8% |
| Q4 2015 | $10,632,000 | +94.4% | 119,902 | +62.3% | 0.01% | +62.5% |
| Q3 2015 | $5,469,000 | +6736.2% | 73,882 | +3772.2% | 0.01% | – |
| Q1 2015 | $80,000 | +15.9% | 1,908 | -57.5% | 0.00% | – |
| Q4 2014 | $69,000 | +25.5% | 4,493 | +3.4% | 0.00% | – |
| Q3 2014 | $55,000 | +5400.0% | 4,345 | +5331.2% | 0.00% | – |
| Q2 2014 | $1,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |